SPI Pharma, Inc. – Trademark Portfolio
Entity Type: 03
SPI Pharma, Inc. holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 14 trademarks are registered and 4 are pending. Notable registered marks include S-TAB, ACTIMASK, BARCROFT, MANNOGEM, and ACTILLETS. The owner is based in New Castle, DE.
321 Cherry Lane
New Castle, DE 19720
Showing of trademarks Trademarks
Trademark Classifications
SPI Pharma, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SPI Pharma, Inc. have?
SPI Pharma, Inc. has 33 U.S. trademarks filed with the USPTO. Of these, 14 registered, 4 pending, 8 abandoned, 7 cancelled.
What trademark classes does SPI Pharma, Inc. file in?
SPI Pharma, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are SPI Pharma, Inc.'s most well-known trademarks?
SPI Pharma, Inc.'s registered trademark portfolio includes well-known marks such as S-TAB, ACTIMASK, BARCROFT, MANNOGEM, and ACTILLETS. These are among 14 currently registered trademarks in the portfolio.
What is SPI Pharma, Inc.'s trademark registration success rate?
SPI Pharma, Inc. has a 48% trademark registration rate, with 14 out of 29 resolved applications resulting in successful registration. Currently, 4 applications are pending review.